APO Research
Talk to an analyst

APO RESEARCH · REPORT

Smallpox Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Smallpox Vaccine Industry Growth and Trends Forecast to 2032

20 December 2025104 pages

Choose your research edition.

Industry ResearchSmallpox Vaccine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Smallpox Vaccine Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Smallpox Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Smallpox Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Smallpox Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Smallpox Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Smallpox Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Smallpox Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Smallpox Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Smallpox Vaccine include CEL-SCI, Chimerix, EpiVax, Nanotherapeutics, Oncovir, SIGA Technologies, Symphogen, TapImmune and Tonix Pharmaceuticals Holding, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Smallpox Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Smallpox Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Smallpox Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Smallpox Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Smallpox Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Smallpox Vaccine Market by Company

CEL-SCI

Chimerix

EpiVax

Nanotherapeutics

Oncovir

SIGA Technologies

Symphogen

TapImmune

Tonix Pharmaceuticals Holding

Bavarian Nordic

Smallpox Vaccine Segment by Type

First Generation

Second Generation

Third Generation

Smallpox Vaccine Segment by Application

Government Hospital And Program

Private Hospitals / Clinicss

Smallpox Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Smallpox Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Smallpox Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Smallpox Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Smallpox Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Smallpox Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of First Generation Table 2. Major Company of Second Generation Table 3. Major Company of Third Generation Table 4. Global Smallpox Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Smallpox Vaccine Sales by Type (2021-2026) & (K Units) Table 6. Global Smallpox Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Smallpox Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Smallpox Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global Smallpox Vaccine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Smallpox Vaccine Sales by Type (2027-2032) & (K Units) Table 11. Global Smallpox Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Smallpox Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Smallpox Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global Smallpox Vaccine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Smallpox Vaccine Sales by Type (2021-2026) & (K Units) Table 16. North America Smallpox Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Smallpox Vaccine Sales by Type (2021-2026) & (K Units) Table 18. Europe Smallpox Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Smallpox Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Smallpox Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Smallpox Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Latin America Smallpox Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Smallpox Vaccine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Smallpox Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Smallpox Vaccine Industry Trends Table 26. Smallpox Vaccine Industry Drivers Table 27. Smallpox Vaccine Industry Opportunities and Challenges Table 28. Smallpox Vaccine Industry Restraints Table 29. Global Smallpox Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Smallpox Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global Smallpox Vaccine Sales by Company (2021-2026) & (K Units) Table 32. Global Smallpox Vaccine Sales Share by Company (2021-2026) Table 33. Global Smallpox Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Smallpox Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Smallpox Vaccine Major Company Production Sites and Headquarters Table 36. Global Smallpox Vaccine Company, Product Type & Application Table 37. Global Smallpox Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Smallpox Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Smallpox Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Smallpox Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Smallpox Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Smallpox Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Smallpox Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global Smallpox Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Smallpox Vaccine Sales by Region (2027-2032) & (K Units) Table 47. Global Smallpox Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Smallpox Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Smallpox Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global Smallpox Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Smallpox Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Smallpox Vaccine Sales by Application (2021-2026) & (K Units) Table 53. Global Smallpox Vaccine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Smallpox Vaccine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Smallpox Vaccine Sales Market Share in Value by Application (2021-2026) Table 56. Global Smallpox Vaccine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Smallpox Vaccine Sales by Application (2027-2032) & (K Units) Table 58. Global Smallpox Vaccine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Smallpox Vaccine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Smallpox Vaccine Sales Market Share in Value by Application (2027-2032) Table 61. Global Smallpox Vaccine Price by Application (2027-2032) & (US$/Unit) Table 62. North America Smallpox Vaccine Sales by Application (2021-2026) & (K Units) Table 63. North America Smallpox Vaccine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Smallpox Vaccine Sales by Application (2021-2026) & (K Units) Table 65. Europe Smallpox Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Smallpox Vaccine Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Smallpox Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Smallpox Vaccine Sales by Application (2021-2026) & (K Units) Table 69. Latin America Smallpox Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Smallpox Vaccine Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Smallpox Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. CEL-SCI Company Information Table 73. CEL-SCI Business Overview Table 74. CEL-SCI Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. CEL-SCI Smallpox Vaccine Product Portfolio Table 76. CEL-SCI Recent Development Table 77. Chimerix Company Information Table 78. Chimerix Business Overview Table 79. Chimerix Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Chimerix Smallpox Vaccine Product Portfolio Table 81. Chimerix Recent Development Table 82. EpiVax Company Information Table 83. EpiVax Business Overview Table 84. EpiVax Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. EpiVax Smallpox Vaccine Product Portfolio Table 86. EpiVax Recent Development Table 87. Nanotherapeutics Company Information Table 88. Nanotherapeutics Business Overview Table 89. Nanotherapeutics Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Nanotherapeutics Smallpox Vaccine Product Portfolio Table 91. Nanotherapeutics Recent Development Table 92. Oncovir Company Information Table 93. Oncovir Business Overview Table 94. Oncovir Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Oncovir Smallpox Vaccine Product Portfolio Table 96. Oncovir Recent Development Table 97. SIGA Technologies Company Information Table 98. SIGA Technologies Business Overview Table 99. SIGA Technologies Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. SIGA Technologies Smallpox Vaccine Product Portfolio Table 101. SIGA Technologies Recent Development Table 102. Symphogen Company Information Table 103. Symphogen Business Overview Table 104. Symphogen Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Symphogen Smallpox Vaccine Product Portfolio Table 106. Symphogen Recent Development Table 107. TapImmune Company Information Table 108. TapImmune Business Overview Table 109. TapImmune Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. TapImmune Smallpox Vaccine Product Portfolio Table 111. TapImmune Recent Development Table 112. Tonix Pharmaceuticals Holding Company Information Table 113. Tonix Pharmaceuticals Holding Business Overview Table 114. Tonix Pharmaceuticals Holding Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Tonix Pharmaceuticals Holding Smallpox Vaccine Product Portfolio Table 116. Tonix Pharmaceuticals Holding Recent Development Table 117. Bavarian Nordic Company Information Table 118. Bavarian Nordic Business Overview Table 119. Bavarian Nordic Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Bavarian Nordic Smallpox Vaccine Product Portfolio Table 121. Bavarian Nordic Recent Development Table 122. North America Smallpox Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America Smallpox Vaccine Sales by Country (2021-2026) & (K Units) Table 124. North America Smallpox Vaccine Sales Market Share by Country (2021-2026) Table 125. North America Smallpox Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America Smallpox Vaccine Sales Market Share Forecast by Country (2027-2032) Table 127. North America Smallpox Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Smallpox Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Smallpox Vaccine Market Share by Country (2021-2026) Table 130. North America Smallpox Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Smallpox Vaccine Market Share Forecast by Country (2027-2032) Table 132. Europe Smallpox Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe Smallpox Vaccine Sales by Country (2021-2026) & (K Units) Table 134. Europe Smallpox Vaccine Sales Market Share by Country (2021-2026) Table 135. Europe Smallpox Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe Smallpox Vaccine Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Smallpox Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Smallpox Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Smallpox Vaccine Market Share by Country (2021-2026) Table 140. Europe Smallpox Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Smallpox Vaccine Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Smallpox Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Smallpox Vaccine Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific Smallpox Vaccine Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Smallpox Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific Smallpox Vaccine Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Smallpox Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Smallpox Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Smallpox Vaccine Market Share by Country (2021-2026) Table 150. Asia-Pacific Smallpox Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Smallpox Vaccine Market Share Forecast by Country (2027-2032) Table 152. Latin America Smallpox Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America Smallpox Vaccine Sales by Country (2021-2026) & (K Units) Table 154. Latin America Smallpox Vaccine Sales Market Share by Country (2021-2026) Table 155. Latin America Smallpox Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America Smallpox Vaccine Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Smallpox Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Smallpox Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Smallpox Vaccine Market Share by Country (2021-2026) Table 160. Latin America Smallpox Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Smallpox Vaccine Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Smallpox Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Smallpox Vaccine Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Smallpox Vaccine Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Smallpox Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa Smallpox Vaccine Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Smallpox Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Smallpox Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Smallpox Vaccine Market Share by Country (2021-2026) Table 170. Middle East and Africa Smallpox Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Smallpox Vaccine Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Smallpox Vaccine Distributors List Table 175. Smallpox Vaccine Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Smallpox Vaccine Image Figure 2. Global Smallpox Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Smallpox Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Smallpox Vaccine Sales (2021-2032) & (K Units) Figure 5. First Generation Image Figure 6. Global First Generation Sales YoY Growth (2021-2032) & (K Units) Figure 7. Second Generation Image Figure 8. Global Second Generation Sales YoY Growth (2021-2032) & (K Units) Figure 9. Third Generation Image Figure 10. Global Third Generation Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Smallpox Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Smallpox Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America Smallpox Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America Smallpox Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe Smallpox Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Smallpox Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Smallpox Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Smallpox Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Smallpox Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Smallpox Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Smallpox Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Smallpox Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Smallpox Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Government Hospital And Program Image Figure 26. Global Government Hospital And Program Sales YoY Growth (2021-2032) & (K Units) Figure 27. Private Hospitals / Clinicss Image Figure 28. Global Private Hospitals / Clinicss Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Smallpox Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Smallpox Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Smallpox Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Smallpox Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Smallpox Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Smallpox Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Smallpox Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Smallpox Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Smallpox Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Smallpox Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Smallpox Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Smallpox Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Smallpox Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Smallpox Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Smallpox Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Smallpox Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Smallpox Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Smallpox Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Smallpox Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Smallpox Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Smallpox Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Smallpox Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Smallpox Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Smallpox Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Smallpox Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Smallpox Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Smallpox Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Smallpox Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Smallpox Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Smallpox Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Smallpox Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Smallpox Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Smallpox Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Smallpox Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • First Generation
  • Second Generation
  • Third Generation
Applications
  • Government Hospital And Program
  • Private Hospitals / Clinicss
Companies covered
  • CEL-SCI
  • Chimerix
  • EpiVax
  • Nanotherapeutics
  • Oncovir
  • SIGA Technologies
  • Symphogen
  • TapImmune
  • Tonix Pharmaceuticals Holding
  • Bavarian Nordic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Smallpox Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Smallpox Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Smallpox Vaccine Market by Type
  6. 1.3.1 First Generation
  7. 1.3.2 Second Generation
  8. 1.3.3 Third Generation
  9. 1.4 Global Smallpox Vaccine Market Size by Type
  10. 1.4.1 Global Smallpox Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Smallpox Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Smallpox Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Smallpox Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Smallpox Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Smallpox Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Smallpox Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Smallpox Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Smallpox Vaccine Industry Trends
  2. 2.2 Smallpox Vaccine Industry Drivers
  3. 2.3 Smallpox Vaccine Industry Opportunities and Challenges
  4. 2.4 Smallpox Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Smallpox Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Smallpox Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Smallpox Vaccine Price (2021-2026)
  4. 3.4 Global Smallpox Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Smallpox Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Smallpox Vaccine Company, Product Type & Application
  7. 3.7 Global Smallpox Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Smallpox Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Smallpox Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Smallpox Vaccine Tier 1, Tier 2, and Tier 3
4 Smallpox Vaccine Regional Status and Outlook
  1. 4.1 Global Smallpox Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Smallpox Vaccine Historic Market Size by Region
  3. 4.2.1 Global Smallpox Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Smallpox Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Smallpox Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Smallpox Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Smallpox Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Smallpox Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Smallpox Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Smallpox Vaccine by Application
  1. 5.1 Smallpox Vaccine Market by Application
  2. 5.1.1 Government Hospital And Program
  3. 5.1.2 Private Hospitals / Clinicss
  4. 5.2 Global Smallpox Vaccine Market Size by Application
  5. 5.2.1 Global Smallpox Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Smallpox Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Smallpox Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Smallpox Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Smallpox Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Smallpox Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Smallpox Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Smallpox Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CEL-SCI
  2. 6.1.1 CEL-SCI Company Information
  3. 6.1.2 CEL-SCI Business Overview
  4. 6.1.3 CEL-SCI Smallpox Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CEL-SCI Smallpox Vaccine Product Portfolio
  6. 6.1.5 CEL-SCI Recent Developments
  7. 6.2 Chimerix
  8. 6.2.1 Chimerix Company Information
  9. 6.2.2 Chimerix Business Overview
  10. 6.2.3 Chimerix Smallpox Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chimerix Smallpox Vaccine Product Portfolio
  12. 6.2.5 Chimerix Recent Developments
  13. 6.3 EpiVax
  14. 6.3.1 EpiVax Company Information
  15. 6.3.2 EpiVax Business Overview
  16. 6.3.3 EpiVax Smallpox Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 EpiVax Smallpox Vaccine Product Portfolio
  18. 6.3.5 EpiVax Recent Developments
  19. 6.4 Nanotherapeutics
  20. 6.4.1 Nanotherapeutics Company Information
  21. 6.4.2 Nanotherapeutics Business Overview
  22. 6.4.3 Nanotherapeutics Smallpox Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nanotherapeutics Smallpox Vaccine Product Portfolio
  24. 6.4.5 Nanotherapeutics Recent Developments
  25. 6.5 Oncovir
  26. 6.5.1 Oncovir Company Information
  27. 6.5.2 Oncovir Business Overview
  28. 6.5.3 Oncovir Smallpox Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Oncovir Smallpox Vaccine Product Portfolio
  30. 6.5.5 Oncovir Recent Developments
  31. 6.6 SIGA Technologies
  32. 6.6.1 SIGA Technologies Company Information
  33. 6.6.2 SIGA Technologies Business Overview
  34. 6.6.3 SIGA Technologies Smallpox Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 SIGA Technologies Smallpox Vaccine Product Portfolio
  36. 6.6.5 SIGA Technologies Recent Developments
  37. 6.7 Symphogen
  38. 6.7.1 Symphogen Company Information
  39. 6.7.2 Symphogen Business Overview
  40. 6.7.3 Symphogen Smallpox Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Symphogen Smallpox Vaccine Product Portfolio
  42. 6.7.5 Symphogen Recent Developments
  43. 6.8 TapImmune
  44. 6.8.1 TapImmune Company Information
  45. 6.8.2 TapImmune Business Overview
  46. 6.8.3 TapImmune Smallpox Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 TapImmune Smallpox Vaccine Product Portfolio
  48. 6.8.5 TapImmune Recent Developments
  49. 6.9 Tonix Pharmaceuticals Holding
  50. 6.9.1 Tonix Pharmaceuticals Holding Company Information
  51. 6.9.2 Tonix Pharmaceuticals Holding Business Overview
  52. 6.9.3 Tonix Pharmaceuticals Holding Smallpox Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Tonix Pharmaceuticals Holding Smallpox Vaccine Product Portfolio
  54. 6.9.5 Tonix Pharmaceuticals Holding Recent Developments
  55. 6.10 Bavarian Nordic
  56. 6.10.1 Bavarian Nordic Company Information
  57. 6.10.2 Bavarian Nordic Business Overview
  58. 6.10.3 Bavarian Nordic Smallpox Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bavarian Nordic Smallpox Vaccine Product Portfolio
  60. 6.10.5 Bavarian Nordic Recent Developments
7 North America by Country
  1. 7.1 North America Smallpox Vaccine Sales by Country
  2. 7.1.1 North America Smallpox Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Smallpox Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Smallpox Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Smallpox Vaccine Market Size by Country
  6. 7.2.1 North America Smallpox Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Smallpox Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Smallpox Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Smallpox Vaccine Sales by Country
  2. 8.1.1 Europe Smallpox Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Smallpox Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Smallpox Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Smallpox Vaccine Market Size by Country
  6. 8.2.1 Europe Smallpox Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Smallpox Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Smallpox Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Smallpox Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Smallpox Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Smallpox Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Smallpox Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Smallpox Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Smallpox Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Smallpox Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Smallpox Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Smallpox Vaccine Sales by Country
  2. 10.1.1 South America Smallpox Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Smallpox Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Smallpox Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Smallpox Vaccine Market Size by Country
  6. 10.2.1 South America Smallpox Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Smallpox Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Smallpox Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Smallpox Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Smallpox Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Smallpox Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Smallpox Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Smallpox Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Smallpox Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Smallpox Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Smallpox Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Smallpox Vaccine Value Chain Analysis
  2. 12.1.1 Smallpox Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Smallpox Vaccine Production Mode & Process
  7. 12.2 Smallpox Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Smallpox Vaccine Distributors
  10. 12.2.3 Smallpox Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst